|
Prognostic relevance of cytogenetic systems in myelodysplastic syndromes.
|
Mar 2012
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT
|
Sep 2016
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Prognostic models in predicting outcomes in myelodysplastic syndromes after hypomethylating agent failure
|
Mar 2017
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Prognostic models in myelodysplastic syndromes
|
Jun 2015
|
Lancet Haematol
|
myelodysplastic syndromes (MDS)
|
|
Prognostic models in myelodysplastic syndromes
|
Dec 2013
|
Hematology Am Soc Hematol Educ Program
|
myelodysplastic syndromes (MDS)
|
|
Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine.
|
Jun 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Prognostic Factors Associated With Disease Progression and Overall Survival in Patients With Myelodysplastic Syndromes Treated With Decitabine.
|
Dec 2012
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
|
Prognostic factors and risk models in myelodysplastic syndromes
|
Sep 2013
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
|
Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: A multicenter retrospective study
|
Mar 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Pro-inflammatory proteins S100A9 and TNFα suppress erythropoietin elaboration in myelodysplastic syndromes
|
Oct 2017
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
